Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bogwitz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|November 19, 2013
The Angelina Jolie effectPaul A James, Gillian Mitchell, Michael Bogwitz, et al.
Psychology & Health|April 2, 2019
Living with Hereditary Haemorrhagic Telangiectasia: stigma, coping with unpredictable symptoms, and self-advocacyAdrienne Sexton, Bridget Gargan, Jessica Taylor, et al.
Journal of Genetic Counseling|October 19, 2007
Letter to the editor journal of genetic counseling. When you care enough to do your very best: genetic counselor experiences of compassion fatigueMargaret Sahhar, Michael Bogwitz, Erica Brown, et al.
European Journal of Medical Genetics|June 6, 2020
Impact of direct-to-consumer genetic testing on Australian clinical genetics servicesMichael Millward, Jane Tiller, Michael Bogwitz, et al.
Internal Medicine Journal|March 23, 2017
Cohort study of Gorlin syndrome with emphasis on standardised phenotyping and quality of life assessmentAamira J Huq, Michael Bogwitz, Alexandra Gorelik, et al.
European Journal of Medical Genetics|November 6, 2017
A rapid scoring tool to assess mutation probability in patients with inherited cardiac disordersDominica Zentner, Tina Thompson, Jessica Taylor, et al.
Internal Medicine Journal|October 6, 2018
Absence of renal phenotype in hereditary haemorrhagic telangiectasiaLachlan Healy, Kathleen Nicholls, Robert Gibson, et al.
Future Oncology (London, England)|February 7, 2026
Consumer acceptability of a cancer registry-driven familial cancer testing pathway: a qualitative study using the Theoretical Framework of AcceptabilityZoe Fehlberg, Sue M Evans, Maria Bechelli, et al.
Development Genes and Evolution|May 4, 2005
Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye developmentKristina Jackson Behan, Jason Fair, Shalini Singh, et al.
Pathology|October 24, 2013
Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinomaAnthony J Gill, Lara Lipton, Jessica Taylor, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|November 19, 2013
The Angelina Jolie effectPaul A James, Gillian Mitchell, Michael Bogwitz, et al.
Psychology & Health|April 2, 2019
Living with Hereditary Haemorrhagic Telangiectasia: stigma, coping with unpredictable symptoms, and self-advocacyAdrienne Sexton, Bridget Gargan, Jessica Taylor, et al.
Journal of Genetic Counseling|October 19, 2007
Letter to the editor journal of genetic counseling. When you care enough to do your very best: genetic counselor experiences of compassion fatigueMargaret Sahhar, Michael Bogwitz, Erica Brown, et al.
European Journal of Medical Genetics|June 6, 2020
Impact of direct-to-consumer genetic testing on Australian clinical genetics servicesMichael Millward, Jane Tiller, Michael Bogwitz, et al.
Internal Medicine Journal|March 23, 2017
Cohort study of Gorlin syndrome with emphasis on standardised phenotyping and quality of life assessmentAamira J Huq, Michael Bogwitz, Alexandra Gorelik, et al.
European Journal of Medical Genetics|November 6, 2017
A rapid scoring tool to assess mutation probability in patients with inherited cardiac disordersDominica Zentner, Tina Thompson, Jessica Taylor, et al.
Internal Medicine Journal|October 6, 2018
Absence of renal phenotype in hereditary haemorrhagic telangiectasiaLachlan Healy, Kathleen Nicholls, Robert Gibson, et al.
Future Oncology (London, England)|February 7, 2026
Consumer acceptability of a cancer registry-driven familial cancer testing pathway: a qualitative study using the Theoretical Framework of AcceptabilityZoe Fehlberg, Sue M Evans, Maria Bechelli, et al.
Development Genes and Evolution|May 4, 2005
Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye developmentKristina Jackson Behan, Jason Fair, Shalini Singh, et al.
Pathology|October 24, 2013
Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinomaAnthony J Gill, Lara Lipton, Jessica Taylor, et al.
Pageof 2